CURETECH LTD has a total of 26 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Israel and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are METAGEN GESELLSCHAFT FUER GENOMFORSCHUNG MBH, CORVIDIA THERAPEUTICS INC and IMCLONE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Israel | 4 | |
#3 | Australia | 3 | |
#4 | China | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hong Kong | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Rotem-Yehudar Rinat | 15 |
#2 | Rodionov Galina | 8 |
#3 | Schickler Michael | 6 |
#4 | Hardy Britta | 5 |
#5 | Klapper Leah | 5 |
#6 | Jones Steven Tarran | 3 |
#7 | Rinat Rotem-Yehudar | 3 |
#8 | Michael Schickler | 2 |
#9 | Raiter Annat | 2 |
#10 | Rodionov Galina G | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015201986A1 | Monoclonal antibodies for tumor treatment | |
US9580504B1 | Pidilizumab monoclonal antibody therapy following stem cell transplantation | |
IL207478D0 | נוגדני bat חד–שבטיים מואנשים בשילוב עם כמותרפיה לטיפול בגידולים | |
AU2009213738A1 | Monoclonal antibodies for tumor treatment | |
IL149820D0 | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |